secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001193125-24-175077
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Medpace director Ashley Keating resigns; Dr. Dani Zander elected to board
-------------------------------------------------------------------------

- Ashley M. Keating resigned from the Board effective June 30, 2024, with no disagreement on operations, policies, or practices.
- Dr. Dani S. Zander elected as Class III director effective July 1, 2024, and appointed to the Nominating and Governance Committee.
- Dr. Zander is Chair of Pathology at University of Cincinnati, formerly at Penn State, and has served as president of multiple pathology societies.
- Dr. Zander received an option to purchase 824 shares at the July 1, 2024 closing price, with a 7-year term, under standard non-employee director compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000119312524175077/0001193125-24-175077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000119312524175077/d822266d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-175077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer